The average one-year price target for Editas Medicine (NASDAQ:EDIT) has been revised to 13.68 / share. This is an increase of 5.56% from the prior estimate of 12.96 dated June 1, 2023. The price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback